CSIR in the news..

An aggregation of news on the web about CSIR and its laboratories

Rs.2.84-lakh cancer drug will soon cost just Rs. 8,880

13 March 2012

MUMBAI/NEW DELHI: Cancer-treatment drug Nexavar will soon be available to patients at Rs. 8,880 a pack of 120 tablets, thanks to India invoking an international trade rule allowing the generic production of an unaffordable drug that is patented.

…..Welcoming the development, Director-General of the Central government’s Council for Scientific and Industrial Research Samir Brahmachari said it was a heart-warming decision as the drug would be available at just three per cent of the current price.

Dr. Brahmachari, who has initiated an open source drug discovery programme in the CSIR to help develop drugs for tuberculosis and other diseases of public health importance, noted that in the health sector at least there was a need to strike a balance between the rights of the patent-holders and the needs of the users. “There can be profits. But, not profiteering at the cost of the patients.”….

Read more: http://www.thehindu.com/news/national/article2988811.ece


Written by csirindia

March 13, 2012 at 7:50 pm

Posted in CSIR

%d bloggers like this: